US NYSE

Bristol-Myers Squibb Company

Pharmaceutical manufacturer that stuffed wholesale distribution channels with $2B in excess inventory using financial incentives.

CORPORATE IDENTIFIERS & DOSSIER
  • Entity Name: Bristol-Myers Squibb Company
  • Country of Domicile: US
  • Listing & Ticker: NYSE (BMY).
  • CIK / LEI Identifier: 0000014272.
  • Industry Classification: Pharmaceutical Preparations (SIC 2834).
  • Cumulative Overstatement: $2.0B across 1 enforcement episode(s).
  • Assessed Penalties: $150.0M.

PRIMARY ENFORCEMENT CASES INVOLVING BRISTOL-MYERS SQUIBB COMPANY

1 CASE DOSSIERS
Case Title Status Primary Scheme Overstatement Total Penalties Action Date
Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives Settled, neither admitted nor denied channel stuffing $2.0B $150.0M September 20, 2006

FORENSIC PROFILE: BRISTOL-MYERS SQUIBB: $2B CHANNEL STUFFING WITH WHOLESALER INCENTIVES

FULL CASE DOSSIER →

Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.

The company manipulated its accounting records by executing schemes under channel-stuffing. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.

Fraud Window: January 1, 2004 to December 31, 2006 • Primary Regulator: U.S. Securities and Exchange Commission • Auditor: PricewaterhouseCoopers LLP

Documented Accounting Irregularities & Regulatory Findings

  • CHANNEL STUFFING: Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.

Primary Public Dockets & Actions

  • [ENF-2004-bristol-myers-squibb] Enforcement Action: Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives (September 20, 2006): Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand. Official Record ↗